Use of Placebo in Pediatric Inflammatory Bowel Diseases
نویسندگان
چکیده
منابع مشابه
Ultrasonography in pediatric inflammatory bowel diseases
Inflammatory bowel diseases (IBD) are an heterogeneous group of chronic disorders of intestinal inflammation characterised by periods of remission and exacerbation. Crohn’s disease (CD) an ulcerative colitis (UC) are the two major clinical subtypes of IBD [1]. CD is caracterised by transmural inflammation in a non contiguos pattern anywhere from the mouth to the anus. Ileocolonic region is the ...
متن کاملepidemiology of pediatric inflammatory bowel diseases in southern iran
background there are great variations in the incidence and prevalence of inflammatory bowel diseases (ibd) among different populations. epidemiologic studies mainly come from north america and europe. studies from iran are mostly data on the adult population from the northern region of the country. methods medical records of 37 pediatric patients (≤ 18 years of age) admitted in the pediatric ga...
متن کاملEpidemiology of Pediatric Inflammatory Bowel Diseases in Southern Iran
BACKGROUND There are great variations in the incidence and prevalence of inflammatory bowel diseases (IBD) among different populations. Epidemiologic studies mainly come from North America and Europe. Studies from Iran are mostly data on the adult population from the northern region of the country. METHODS Medical records of 37 pediatric patients (≤ 18 years of age) admitted in the Pediatric Ga...
متن کاملDysbiosis in the Pathogenesis of Pediatric Inflammatory Bowel Diseases
Inflammatory bowel diseases (IBDs) are chronic inflammatory conditions of the gastrointestinal tract that occur in genetically susceptible individuals. Crohn's disease (CD) and ulcerative colitis (UC) are two major types of IBD. In about 20-25% of patients, disease onset is during childhood and pediatric IBD can be considered the best model for studying immunopathogentic mechanisms. The fundame...
متن کاملUse of methotrexate in patients with inflammatory bowel diseases.
Methotrexate (MTX) is one of the immunosuppressants commonly used in inflammatory bowel diseases. There is very good evidence for its use in patients with steroid-dependent or steroid-refractory Crohn's disease for induction as well as maintenance of remission. Optimal dose as well as mode of application is still a matter of debate. The only large randomised controlled trials used 25 mg/wk for ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Pediatric Gastroenterology & Nutrition
سال: 2016
ISSN: 0277-2116
DOI: 10.1097/mpg.0000000000001024